AN2 Therapeutics ANTX
NASDAQ ANTX
$4.46 +0.13 (+3.00%)
At close: Nov 11, 2026 · 4:00 PM EST

AN2 Therapeutics (ANTX) Liabilities and Shareholders Equity (2021 - 2026)

Updated

AN2 Therapeutics (ANTX) reported Liabilities and Shareholders Equity of $81.68 million for Q2 2026, up 7.7% from $75.83 million a year earlier but down 6.6% from the prior quarter.

Analysis

AN2 Therapeutics (ANTX) Liabilities and Shareholders Equity (2021 - 2026) Analysis & Trends

At the end of FY2025, AN2 Therapeutics posted Liabilities and Shareholders Equity of $61.95 million, down 32.7% from FY2024.

  • Liabilities and Shareholders Equity has a four-year compound annual growth rate of -1.3% (FY2021 to FY2025).
  • By year, Liabilities and Shareholders Equity came in at $92.09 million in FY2024 (-33.6%), $138.74 million in FY2023 (+35.3%), $102.56 million in FY2022 (+57.0%) and $65.32 million in FY2021.
  • Five-year quarterly Liabilities and Shareholders Equity spans a low of $61.95 million in Q4 2025 and a high of $153.81 million in Q3 2023.
  • Year over year, Liabilities and Shareholders Equity gained in two of the last eight quarters, with an average decline of 22.7%.
  • The high point for year-over-year Liabilities and Shareholders Equity in five years was Q4 2022 (growth of 57.0%); the low point was Q3 2024 (a decline of 36.5%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $87.49 million (Q1 2026), $61.95 million (Q4 2025) and $67.24 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 148.07 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 197.43 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 147.68 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 132.77 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 119.92 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 96.05 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 51.41 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 205.00 Bn
10 AN2 Therapeutics 164.30 Mn -121.79 Mn - 81.96 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 81.96 Mn
Jun 30, 2026 81.68 Mn
Mar 31, 2026 87.49 Mn
Dec 31, 2025 61.95 Mn
Sep 30, 2025 67.24 Mn
Jun 30, 2025 75.83 Mn
Mar 31, 2025 81.34 Mn
Dec 31, 2024 92.09 Mn
Sep 30, 2024 97.69 Mn
Jun 30, 2024 108.48 Mn
Mar 31, 2024 121.26 Mn
Dec 31, 2023 138.74 Mn
Sep 30, 2023 153.81 Mn
Jun 30, 2023 98.93 Mn
Mar 31, 2023 91.08 Mn
Dec 31, 2022 102.56 Mn
Sep 30, 2022 110.01 Mn
Jun 30, 2022 120.02 Mn
Mar 31, 2022 120.50 Mn
Dec 31, 2021 65.32 Mn
API Access

AN2 Therapeutics Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=ANTX&period=max&api_key=YOUR_API_KEY